Literature DB >> 24529458

Management of unruptured brain arteriovenous malformations.

Jared Knopman1, Philip E Stieg2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24529458     DOI： 10.1016/S0140-6736(14)60001-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Viewpoints on the ARUBA trial.

Authors:  J P Mohr; A Hartmann; H Kim; J Pile-Spellman; C Stapf
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-26       Impact factor: 3.825

2.  [Cerebral arteriovenous malformations: Results of the ARUBA study].

Authors:  M-A Weber
Journal:  Radiologe       Date:  2014-05       Impact factor: 0.635

3.  Treatment and outcomes of ARUBA-eligible patients with unruptured brain arteriovenous malformations at a single institution.

Authors:  W Caleb Rutledge; Adib A Abla; Jeffrey Nelson; Van V Halbach; Helen Kim; Michael T Lawton
Journal:  Neurosurg Focus       Date:  2014-09       Impact factor: 4.047

4.  Determining blood flow direction from short neurovascular surgical microscope videos.

Authors:  Reid Vassallo; Adam Rankin; Stephen P Lownie; Hitoshi Fukuda; Hidetoshi Kasuya; Benjamin W Y Lo; Terry Peters; Yiming Xiao
Journal:  Healthc Technol Lett       Date:  2019-11-26

Review 5.  Updates in arteriovenous malformation management: the post-ARUBA era.

Authors:  James Feghali; Judy Huang
Journal:  Stroke Vasc Neurol       Date:  2019-09-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.